Clinical Trials Browser

Phase 1/2 × Terminated × anlotinib × Clear all

NCT06507891 2024-07-18

A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02558348 2019-06-19

AL3818

Phase 1/2 Terminated

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms